Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease
PHASE3
The primary objective of this study was to compare the long-term (12-week) ...
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma
PHASE2
The primary goal of this trial is to compare the efficacy and safety of COM...
Status
Completed
Location
1012.57.121 Boehringer Ingelheim Investigational Site